We refer to our announcements dated 28 September 2020 and 6 July 2021 in regards to the Memorandum of Understanding (“MOU”) entered into between the Company and Institut Jantung Negara Sdn Bhd (“IJN”) [Registration No. 199201014291 (245794-V), a private limited company incorporated in Malaysia for the proposed collaboration in the area of commercial development of Covid-19 vaccine in Malaysia.
The Board of Directors of BKCB wishes to announce that as of todate, the MOU on the above matter remain status quo and any further development thereon shall be announced in due course.
This announcement is dated 6 October 2021.